
    
      The objectives of the study as defined by the specific requirements of Transparency
      Commission are as follows:

        -  To describe the characteristics of the patients treated with Xigris®

             -  socio-demographic characteristics,

             -  clinical profile

        -  To determine the conditions of use of Xigris®

             -  To describe previous treatments,

             -  To observe delay before Xigris® initiation,

             -  To describe dose, duration of treatment,

             -  To study the concomitant treatments and the associated treatments

        -  To describe the clinical evolution of the patients

             -  To observe mortality after 1 month

             -  To describe reasons of death
    
  